Skip to content

TABOLCEA PAVEL

Active
Private limited companyfounded 2016active for 10 yearsRue de la Bouvrée 6, 1421 Braine-l'Alleud, BelgiumKBO/BCE: BE 0663.593.826
Summary

TABOLCEA PAVEL has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €99,063 and a net result of €25,654. Equity has been stable since 2018 (±0% per year). Its solvency ranks better than 23% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 29-09-2016 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment units
2.256.879.204 1421 Braine-l'Alleud, since 29-09-2016
2.382.554.184 1400 Nivelles, since 01-01-2026
Financial year end
31 December
Peppol
Reachable since 01-04-2026

Board and ownership

Board

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€76,513
▼ 17.8%
Turnover
≈ €170,000
estimated
Profit
€25,654
▼ 53.2%
Equity
€99,063
▲ 34.9%
Total assets
€388,019
▲ 249%
Score breakdownraises riskProfit of €25,654 (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €388,019Figures for financial year 2025 (filed on 01-08-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 39% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 51-40
equity 25.5% of total assets
Liquidity 61-29
short-term debt 10.1% · cash 8.7%
Profitability 77-23
return on assets 6.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.72 (3.76 in 2024), above the usual 1.5. Short-term debt is 10.1% and cash 8.7% of total assets. However, 74.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 23% of them on solvency, 39% on liquidity, 21% on profitability and 74% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €388,019
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 01-08-2026)
NBB · annual accounts
raises risk · Profit of €25,654 (financial year 2025)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 23%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €99,063
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
3 days early
2024
1 day early
2023
8 days early
2022
11 days late
2021
9 days early
2020
4 days early
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 2 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €25,654 8 years View

Recent changes

  1. · Gazette deed Change of role: Pavel Oana, from manager to administrateur non statutaire
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as TABOLCEA PAVEL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €350,000 and €438,000, founded between 2015 and 2018.

CompanyTotal assetsGross margin
TABOLCEA PAVEL Braine-l'Alleud€388,019€76,513
Andrew CARLIN - Sophie DECHENE Genappe€420,372€72,697
HAHOANGMEDICAL Koekelberg€354,610€71,784
GUERRA DIAZ NATHALIE GASTRO-ENTEROLOGIE Floreffe€389,427€72,657
Cabinet Médical KAMTO FOTSO Ath€438,046€76,569
DR. CAROLINE NIEWOLD Hasselt€402,284€72,440
DR DATH CATHERINE Anderlecht€350,486€85,262
Full comparison

Key facts about TABOLCEA PAVEL

What is the company number of TABOLCEA PAVEL?
The company number of TABOLCEA PAVEL is 0663.593.826. The VAT number is the same number with BE in front: BE 0663.593.826.
Where is TABOLCEA PAVEL based?
The registered office is at Rue de la Bouvrée 6, 1421 Braine-l'Alleud.Company details
What does TABOLCEA PAVEL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of TABOLCEA PAVEL?
The legal form of TABOLCEA PAVEL is Private limited company (BV).
When was TABOLCEA PAVEL founded?
TABOLCEA PAVEL was founded on 29-09-2016.
Is TABOLCEA PAVEL still active?
Yes, TABOLCEA PAVEL is an active enterprise in the KBO register.
What is the turnover of TABOLCEA PAVEL?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €76,513 and 32 comparable companies (NACE 862). It probably lies between €130,000 and €220,000.Financials
Is TABOLCEA PAVEL profitable?
In financial year 2025, TABOLCEA PAVEL made a profit of €25,654.
Where can I find the annual accounts of TABOLCEA PAVEL?
TABOLCEA PAVEL filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of TABOLCEA PAVEL due?
TABOLCEA PAVEL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.